Even HIV-infected individuals who have the greatest challenges in adhering to their antiretroviral therapy (ART) can achieve high adherence on a regimen of one pill taken daily, research shows.
Even HIV-infected individuals who have the greatest challenges in adhering to their antiretroviral therapy (ART) can achieve high adherence on a regimen of one pill taken daily, research shows.
Brief Report: Once-Daily Pill Yields Higher ART Adherence
April 1, 2011